Literature DB >> 8307956

Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase.

D J Hazuda1, A L Wolfe, J C Hastings, H L Robbins, P L Graham, R L LaFemina, E A Emini.   

Abstract

A DNA binding assay was developed for the human immunodeficiency virus type 1 (HIV-1) integrase. The assay was capable of defining discrete complexes between the enzyme and the viral long terminal repeat (LTR) substrate. DNA binding reflected the sequence requirements previously demonstrated for the enzyme's 3'-end processing activity. Binding exhibited a nonlinear dependence on integrase concentration, suggesting that the enzyme functions as a multimer. The oligomeric state was investigated by UV-photo-cross-linking of integrase-LTR oligonucleotide complexes using DNA substrates substituted with 5-bromo-2'-deoxycytidine within the integrase recognition sequence. In the absence of divalent cation, integrase cross-linked to the LTR oligonucleotide as a single species whose mobility by SDS-polyacrylamide gel electrophoresis was consistent with the formation of tetramers. Using these techniques, analysis of the binding properties of integrase mutants demonstrated that the catalytic and sequence-specific DNA binding activities of the enzyme are distinct, involving residues within the conserved "DD(35)E" and zinc finger motifs, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307956

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization.

Authors:  F Yang; O Leon; N J Greenfield; M J Roth
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

2.  The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates.

Authors:  A L Wolfe; P J Felock; J C Hastings; C U Blau; D J Hazuda
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

3.  Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity.

Authors:  B Taddeo; F Carlini; P Verani; A Engelman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  IL-22 suppresses HSV-2 replication in human cervical epithelial cells.

Authors:  Xi-Qiu Xu; Yu Liu; Biao Zhang; Hang Liu; Dan-Dan Shao; Jin-Biao Liu; Xu Wang; Li-Na Zhou; Wen-Hui Hu; Wen-Zhe Ho
Journal:  Cytokine       Date:  2019-07-22       Impact factor: 3.861

5.  A retrotransposon-like sequence linked to the S-locus of Nicotiana alata is expressed in styles in response to touch.

Authors:  J Royo; N Nass; D P Matton; S Okamoto; A E Clarke; E Newbigin
Journal:  Mol Gen Genet       Date:  1996-02-05

6.  Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.

Authors:  A S Reicin; G Kalpana; S Paik; S Marmon; S Goff
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.

Authors:  A Engelman; A B Hickman; R Craigie
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Detection and characterization of a functional complex of human immunodeficiency virus type 1 integrase and its DNA substrate by UV cross-linking.

Authors:  T Yoshinaga; Y Kimura-Ohtani; T Fujiwara
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Inhibition of human immunodeficiency virus integrase by bis-catechols.

Authors:  R L LaFemina; P L Graham; K LeGrow; J C Hastings; A Wolfe; S D Young; E A Emini; D J Hazuda
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.